Case Study: a publicly traded biopharmaceutical company rejects $21M in vendor change orders with Condor Software

Publicly Traded Biopharmaceutical Company rejects $21M in vendor change orders with Condor Software

A publicly traded biopharmaceutical company faced significant challenges in managing its clinical trial accounting, which was entirely dependent on a complex, 20-tab Excel workbook. This manual process was prone to clerical errors, consumed excessive time verifying data accuracy, and was structurally unreliable for producing precise, auditable financials. The team also evaluated a service-heavy alternative from Auxilius but found its offshore-supported, slow-response model operationally untenable. This led them to seek a solution from Condor Software.

Condor Software provided a purpose-built software platform that gave the team full operational control over their financial close process. The solution enabled exact cost tracking, streamlined the management of amendments in progress, and offered a self-service model for real-time updates. By implementing Condor, the company achieved a measurable impact, including successfully challenging and rejecting $21 million in unjustified vendor change orders. Additionally, the team scaled from managing 6 to 14 trials without a proportional increase in staff, strengthened SOX compliance, and completely abandoned their parallel Excel tracking after a single quarter.

Publicly Traded Biopharmaceutical Company